Article
An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
Seminars in oncology - 1 Apr 2011
Godley Lucy A, Cunningham John, Dolan M Eileen, Huang R Stephanie, Gurbuxani Sandeep, McNerney Megan E, Larson Richard A, Leong Hoyee, Lussier Yves, Onel Kenan, Odenike Olatoyosi, Stock Wendy, White Kevin P, Le Beau Michelle M
Abstract excerpt
Traditionally, new scientific advances have been applied quickly to the leukemias based on the ease with which relatively pure samples of malignant cells can be obtained. Currently, our arsenal of approaches used to characterize an individual's acute myeloid leukemia (AML) combines hematopathologic evaluation, flow cytometry, cytogenetic analysis, and molecular studies focused on a few key genes. The advent of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.